21 CFR 558.464
§ 558.464 Poloxalene.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 558.464, § 558.464 Poloxalene, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87883
- Permanent ID
ys:prov:87883@1- SHA-256
8747cf2e036e75fcf4e5ea0584a57584f8bde90cc729f36c2933d13af737b7f3
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Dry Type A medicated articles containing 53 percent poloxalene or liquid Type A medicated articles containing 99.5 percent poloxalene.
(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Related tolerances. See § 556.517 of this chapter.
(d) Conditions of use.
(1) For prevention of legume (alfalfa, clover) and wheat pasture bloat in cattle.
(2) Poloxalene dry Type A article and liquid Type A article must be thoroughly blended and evenly distributed in feed prior to use. This may be accomplished by adding the Type A article to a small quantity of feed, mixing thoroughly, then adding this mixture to the remaining feed and again mixing thoroughly. Dosage is 1 gram of poloxalene per 100 pounds of body weight daily and continued during exposure to bloat producing conditions. If bloating conditions are severe, the dose is doubled. Treatment should be started 2 to 3 days before exposure to bloat-producing conditions. Repeat dosage if animals are exposed to bloat-producing conditions more than 12 hours after the last treatment. Do not exceed the higher dosage levels in any 24-hour period.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.